CAS RN: 102841-42-9

mulberroside A

Product Availability

Choose a grade to view its available package options.

6 package records6 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20260604 100mg In stock Shanghai Inquiry
Batchno.20251130 10mg In stock Shanghai Inquiry
Batchno.20250223 250mg In stock Shanghai Inquiry
Batchno.20260313 25mg In stock Shanghai Inquiry
Batchno.20250222 50mg In stock Shanghai Inquiry
Batchno.20251212 5mg In stock Shanghai Inquiry
  • Product code: starshine_CAS102841-42-9
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

102841-42-9 / (2S,3R,4S,5S,6R)-2-[3-hydroxy-4-[(E)-2-[3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

3-[(1E)-2-[4-(|_-D-Glucopyranosyloxy)-2-hydroxyphenyl]ethenyl]-5-hydroxyphenyl |_-D-glucopyranoside

Standard CAS: 102841-42-9 Multi CAS: Yes

Basic Information

CAS
102841-42-9
Multi CAS
Yes
Molecular Formula
C26H32O14
Molecular Weight
568.500000
Exact Mass
568.179206
SMILES
C1=CC(=C(C=C1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)/C=C/C3=CC(=CC(=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O
InChI
InChI=1S/C26H32O14/c27-9-17-19(31)21(33)23(35)25(39-17)37-14-4-3-12(16(30)8-14)2-1-11-5-13(29)7-15(6-11)38-26-24(36)22(34)20(32)18(10-28)40-26/h1-8,17-36H,9-10H2/b2-1+/t17-,18-,19-,20-,21+,22+,23-,24-,25-,26-/m1/s1
InChIKey
HPSWAEGGWLOOKT-VUNDNAJOSA-N
Synonyms
3-[(1E)-2-[4-(|_-D-Glucopyranosyloxy)-2-hydroxyphenyl]ethenyl]-5-hydroxyphenyl |_-D-glucopyranoside

Computed Properties

Structural Parameters

Heavy atom count
40
Aromatic heavy atom count
12
Fraction Csp3
0.46
Rotatable bonds
8
H-bond acceptors
14
H-bond donors
10
Molar refractivity
133.93
TPSA
239.22

LogP / Solubility

WLOGP
-2.37
MLOGP
-2.05
XLogP3
-0.8
Consensus LogP
-1.74
Log S (ESOL)
-1.56
Class (ESOL)
Soluble
Log S (Ali)
-2.51
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.34
Class (SILICOS-IT)
Moderately soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-7.87

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
9.5

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us